M
ABBV icon

MOTCO’s AbbVie ABBV Stock Holding History

MOTCO’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.26M Sell
19,578
-5
-0% -$1.11K 0.39% 82
2025
Q4 		$4.47M Sell
19,583
-578
-3% -$132K 0.41% 81
2025
Q3 		$4.67M Sell
20,161
-129
-0.6% -$26.3K 0.43% 78
2025
Q2 		$3.84M Sell
20,290
-155
-0.8% -$28.8K 0.37% 89
2025
Q1 		$4.28M Sell
20,445
-1,914
-9% -$372K 0.45% 85
2024
Q4 		$3.97M Sell
22,359
-36
-0.2% -$6.62K 0.41% 88
2024
Q3 		$4.42M Buy
22,395
+20,168
+906% +$3.76M 0.44% 92
2024
Q2 		$382K Buy
2,227
+211
+10% +$35K 0.02% 213
2024
Q1 		$367K Buy
2,016
+58
+3% +$10K 0.02% 221
2023
Q4 		$303K Buy
1,958
+265
+16% +$38.6K 0.02% 217
2023
Q3 		$252K Buy
1,693
+19
+1% +$2.79K 0.02% 211
2023
Q2 		$226K Buy
1,674
+81
+5% +$11.9K 0.01% 219
2023
Q1 		$254K Buy
1,593
+187
+13% +$28.6K 0.02% 209
2022
Q4 		$227K Sell
1,406
-1,296
-48% -$199K 0.02% 216
2022
Q3 		$363K Buy
2,702
+1,531
+131% +$220K 0.03% 188
2022
Q2 		$179K Sell
1,171
-45
-4% -$6.88K 0.01% 243
2022
Q1 		$197K Buy
1,216
+451
+59% +$65.5K 0.01% 238
2021
Q4 		$104K Sell
765
-65
-8% -$7.68K 0.01% 290
2021
Q3 		$90K Hold
830
– – 0.01% 296
2021
Q2 		$93K Buy
830
+110
+15% +$12.4K 0.01% 302
2021
Q1 		$78K Sell
720
-198
-22% -$21.2K 0.01% 301
2020
Q4 		$98K Sell
918
-300
-25% -$28.8K 0.01% 298
2020
Q3 		$106K Buy
1,218
+328
+37% +$30.9K 0.01% 271
2020
Q2 		$87K Buy
890
+31
+4% +$2.73K 0.01% 271
2020
Q1 		$66K Buy
859
+167
+24% +$14.2K 0.01% 281
2019
Q4 		$62K Sell
692
-382
-36% -$31.7K 0.01% 306
2019
Q3 		$82K Sell
1,074
-108,736
-99% -$7.45M 0.01% 284
2019
Q2 		$7.99M Buy
109,810
+7,880
+8% +$619K 0.75% 27
2019
Q1 		$8.21M Buy
101,930
+7,722
+8% +$632K 0.82% 26
2018
Q4 		$8.69M Buy
94,208
+3,576
+4% +$314K 0.96% 22
2018
Q3 		$8.57M Buy
90,632
+41,775
+86% +$3.96M 0.85% 28
2018
Q2 		$4.53M Buy
48,857
+43,401
+795% +$4.24M 0.47% 72
2018
Q1 		$516K Buy
5,456
+1,852
+51% +$203K 0.05% 145
2017
Q4 		$349K Sell
3,604
-1,378
-28% -$130K 0.04% 168
2017
Q3 		$443K Sell
4,982
-34,424
-87% -$2.62M 0.05% 158
2017
Q2 		$2.86M Buy
39,406
+2,235
+6% +$150K 0.3% 109
2017
Q1 		$2.42M Buy
37,171
+635
+2% +$39.9K 0.26% 112
2016
Q4 		$2.29M Buy
36,536
+29,861
+447% +$1.82M 0.26% 112
2016
Q3 		$421K Buy
6,675
+1,130
+20% +$73.2K 0.05% 162
2016
Q2 		$344K Hold
5,545
– – 0.04% 166
2016
Q1 		$317K Hold
5,545
– – 0.04% 169
2015
Q4 		$328K Hold
5,545
– – 0.04% 162
2015
Q3 		$301K Sell
5,545
-267
-5% -$17.4K 0.04% 165
2015
Q2 		$390K Sell
5,812
-136
-2% -$8.88K 0.04% 160
2015
Q1 		$348K Sell
5,948
-5
-0.1% -$302 0.04% 166
2014
Q4 		$390K Buy
5,953
+1,065
+22% +$67.1K 0.04% 170
2014
Q3 		$282K Hold
4,888
– – 0.03% 176
2014
Q2 		$276K Sell
4,888
-135
-3% -$7.08K 0.03% 172
2014
Q1 		$259K Sell
5,023
-300
-6% -$15.2K 0.03% 169
2013
Q4 		$281K Hold
5,323
– – 0.03% 165
2013
Q3 		$238K Hold
5,323
– – 0.03% 176
2013
Q2 		$220K Buy
+5,323
New +$233K 0.03% 182

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MOTCO's ABBV Position: Q1 2026 in Review

MOTCO reduced its AbbVie (ABBV) stake by 0.03% in Q1 2026, selling an estimated $1.11K and leaving 19,578 shares worth $4.26M. The position accounts for 0.39% of the portfolio, ranked #82.

MOTCO first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.69M in Q4 2018. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MOTCO held 19,578 shares of AbbVie worth $4.26M as of Q1 2026.
  • MOTCO sold 5 AbbVie shares in Q1 2026, an estimated $1.11K.
  • AbbVie made up 0.39% of MOTCO's portfolio in Q1 2026, its #82 holding.
  • MOTCO first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • MOTCO's AbbVie position peaked at $8.69M in Q4 2018.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MOTCO's 13F filing for Q1 2026, filed 22 Apr 2026.